• Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Simulate your trials and save time and money!

Engineering simulation is the next big thing in medical development. It can be used to design, rethink and optimize devices before going into clinical trials. These simulations can also be used as an invaluable tool in determining which surgical technique is best to use on a specific patient. Additionally, it allows scientists and physicians to  predict the route of a drug through the body. Because it only involves the calculating power of a computer, it is a fast and cheap alternative providing an enormous competitive advantage for the companies that use it. We spoke with Thierry Marchal, Global Industry Director for healthcare at ANSYS, a world leader in this technology, about this exciting revolution.
In 2008, UGent spin-off ProDigest opened its doors. The company was built around a machine called the SHIME®, an in vitro model for the entire human gastrointestinal tract, complete with stomach and small and large intestines. The immediate interest from the food industry quickly made ProDigest a household name in its niche market. Since its establishment, ProDigest has significantly expanded its technology and activities and has taken on the pharmaceutical and veterinarian industries as additional partners.
  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Engineering simulation is the next big thing in medical development. It can be used to design, rethink and optimize devices before going into clinical trials. These simulations can also be used as an invaluable tool in determining which surgical technique is best to use on a specific patient. Additionally, it allows scientists and physicians to  predict the route of a drug through the body. Because it only involves the calculating power of a computer, it is a fast and cheap alternative providing an enormous competitive advantage for the companies that use it. We spoke with Thierry Marchal, Global Industry Director for healthcare at ANSYS, a world leader in this technology, about this exciting revolution.
In 2008, UGent spin-off ProDigest opened its doors. The company was built around a machine called the SHIME®, an in vitro model for the entire human gastrointestinal tract, complete with stomach and small and large intestines. The immediate interest from the food industry quickly made ProDigest a household name in its niche market. Since its establishment, ProDigest has significantly expanded its technology and activities and has taken on the pharmaceutical and veterinarian industries as additional partners.